In bladder cancer, CD4+ tumor-infiltrating lymphocytes are directly cytotoxic for autologous cancer cells and CD4+ T effectors recognize antigen on cancer cells in a class II-dependent fashion (15). The gene discussed is CD4; the disease is urinary bladder cancer.